Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,687 | 215,507 | 178,120 | 202,290 | 219,428 |
| TOTAL | $199,717 | $220,431 | $183,309 | $207,197 | $224,019 |
| Non-Current Assets | |||||
| PPE Net | 2,485 | 2,728 | 3,002 | 3,277 | 3,395 |
| Other Non-Current Assets | 2,350 | 2,577 | 2,801 | 3,022 | 3,239 |
| TOTAL | $4,835 | $5,305 | $5,803 | $6,299 | $6,634 |
| Total Assets | $204,552 | $225,736 | $189,112 | $213,496 | $230,653 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,711 | 21,610 | 22,327 | 24,032 | 15,754 |
| TOTAL | $26,256 | $23,131 | $23,825 | $25,507 | $17,186 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,869 | 22,266 | 22,653 | 23,037 | 23,414 |
| TOTAL | $21,869 | $22,266 | $22,653 | $23,037 | $23,414 |
| Total Liabilities | $48,125 | $45,397 | $46,478 | $48,544 | $40,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,668 | 47,607 | 37,607 | 37,516 | 37,414 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -320,261 | -292,801 | -265,258 | -239,479 | -210,573 |
| TOTAL | $156,427 | $180,339 | $142,634 | $164,952 | $190,053 |
| Total Liabilities And Equity | $204,552 | $225,736 | $189,112 | $213,496 | $230,653 |